1.2100
+0.0100
+(0.83%)
At close: 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
14,739
14,739
25,459
28,533
12,367
Operating Income
-14,739
-14,739
-25,459
-28,533
-12,367
Net Non Operating Interest Income Expense
794
794
1,238
353
-111
Pretax Income
-13,945
-13,945
-24,221
-28,180
-12,478
Tax Provision
--
--
--
-534
--
Net Income Common Stockholders
-13,945
-13,945
-24,221
-27,646
-12,478
Diluted NI Available to Com Stockholders
-13,945
-13,945
-24,221
-27,646
-12,478
Basic EPS
-0.94
-0.78
-2.06
-2.42
-1.20
Diluted EPS
-0.94
-0.78
-2.06
-2.42
-1.20
Basic Average Shares
14,769.2030
17,952.4320
11,749.9430
11,379.4640
10,373.4320
Diluted Average Shares
14,769.2030
17,952.4320
11,749.9430
11,379.4640
10,373.4320
Rent Expense Supplemental
50
50
81
24
29
Total Expenses
14,739
14,739
25,459
28,533
12,367
Net Income from Continuing & Discontinued Operation
-13,945
-13,945
-24,221
-27,646
-12,478
Normalized Income
-13,945
-13,945
-24,221
-27,646
-12,478
Net Interest Income
794
794
1,238
353
-111
EBIT
-14,739
-14,739
-25,459
-28,533
-12,367
EBITDA
-14,686
-14,686
-25,392
-28,475
-12,333
Reconciled Depreciation
53
53
67
58
34
Net Income from Continuing Operation Net Minority Interest
-13,945
-13,945
-24,221
-27,646
-12,478
Normalized EBITDA
-14,686
-14,686
-25,392
-28,475
-12,333
Tax Rate for Calcs
--
--
--
0
--
12/31/2021 - 2/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.7101
+5.04%
ATYR aTyr Pharma, Inc.
2.9900
-0.66%
MTVA MetaVia Inc.
0.8100
-55.98%
SRRK Scholar Rock Holding Corporation
30.22
+4.46%
INZY Inozyme Pharma, Inc.
0.9972
+2.90%
MIRM Mirum Pharmaceuticals, Inc.
38.63
-2.42%
PTGX Protagonist Therapeutics, Inc.
46.95
+4.26%
ALEC Alector, Inc.
1.0800
+10.11%
PBM Psyence Biomedical Ltd.
0.4940
+3.78%
PYPD PolyPid Ltd.
2.6990
+4.21%